Kähler, Katharina C.

Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

Weber, J. S., Kähler, K. C., & Hauschild, A. (2012) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 1,415

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Weide, B., Martens, A., Hassel, J. C., Berking, C., Postow, M. A., Bisschop, K., Simeone, E., Mangana, J., Schilling, B., Di Giacomo, A. M., et al. (2016) · Clinical Cancer Research

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 589

Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks.

Maron, R. C., Weichenthal, M., Utikal, J. S., Hekler, A., Berking, C., Hauschild, A., Enk, A. H., Haferkamp, S., Klode, J., Schadendorf, D., et al. (2019) · European Journal of Cancer

Cutaneous Melanoma Detection and ManagementAI in cancer detection

Cited by 219

Effectiveness and Tolerability of Ipilimumab: Experiences From 198 Patients Included in a Named-Patient Program in Various Daily-Practice Settings and Multiple Institutions

Eigentler, T. K., Schlaak, M., Hassel, J. C., Loquai, C., Stoffels, I., Gutzmer, R., Pätzold, S., Mohr, P., Keller, U., Starz, H., et al. (2014) · Journal of Immunotherapy

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 23